Clinical Trials Browser

Phase 1 × MAGEA3 protein, human × Clear all

NCT01995708 2024-02-09

CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Phase 1 Completed

28 enrolled 10 charts

Multiple Myeloma

NCT00257738 2019-10-17

0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck

NCT00944580 2017-11-24

A Vaccine Study for High Risk Cancers

Phase 1 Withdrawn

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma

NCT00003792 2013-06-26

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Phase 1 Completed

Melanoma